Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2009 - 2026)

Zimmer Biomet Holdings' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at -$183.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 402.75% year-over-year to -$183.0 million; the TTM figure through Mar 2026 stood at -$44.8 million (up 81.26% YoY), while the FY2025 annual figure was $101.8 million, up 131.61% from the prior year.
• Change in Accured Expenses was -$183.0 million for Q1 2026 at Zimmer Biomet Holdings, down from $112.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $164.2 million in Q4 2023 to a low of -$183.0 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$20.9 million across 5 years, with a median of -$34.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses slumped 477.36% in 2023, then soared 223.67% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $104.6 million in 2022, then soared by 56.98% to $164.2 million in 2023, then slumped by 171.44% to -$117.3 million in 2024, then jumped by 196.25% to $112.9 million in 2025, then slumped by 262.09% to -$183.0 million in 2026.
• The last three Change in Accured Expenses figures came in at -$183.0 million (Q1 2026), $112.9 million (Q4 2025), and -$51.5 million (Q3 2025), per Business Quant data.